SEC Form 4 · accession 0001209191-18-046100
GENOMIC HEALTH INC · GHDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fred E Cohen
Director
Period of report
Aug 7, 2018
Accepted (ET)
Aug 9, 2018 · 7:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131324
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 7, 2018 | M | 8,250 | $25.79 | A | 75,572 | D | |
| Common StockF1,F2 | Aug 7, 2018 | S | 6,850 | $56.0971 | D | 68,722 | D | |
| Common StockF1,F3 | Aug 7, 2018 | S | 1,400 | $56.8107 | D | 67,322 | D | |
| Common Stock | holding | — | — | — | 6,068 | I | By the Jane K Cohen Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy) | $25.79 | Aug 7, 2018 | M | 8,250 | D | Jun 10, 2012 | Jun 10, 2021 | Common Stock | 8,250 | 0 | D |
Explanation of responses
- F1Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated.
- F2Represents weighted average sale price. Actual sale prices ranged from $55.65 to $56.64.
- F3Represents weighted average sale price. Actual sale prices ranged from $56.65 to $56.92.